Volume 137, Issue 6 , Pages 1436-1442.e2, June 2009
Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery
Objective
Anesthetic preconditioning may contribute to the cardioprotective effects of sevoflurane in patients having coronary artery bypass surgery. We investigated whether 2 different sevoflurane administration protocols can induce preconditioning in patients having coronary artery bypass.
Methods
Thirty patients were randomly allocated to 1 of 3 groups. All patients received a total intravenous anesthesia with sufentanil (0.3 μg−1 · kg· h−1) and propofol as target controlled infusion (2.5 μg/mL). The control group had no further intervention; 10 minutes prior to establishing the extracorporeal circulation, patients of the sevoflurane-I group received 1 minimum alveolar concentration of sevoflurane for 5 minutes. Patients of the sevoflurane-II group received (2 times) 5 minutes of sevoflurane, interspersed by 5-minute washout 10 minutes prior to extracorporeal circulation. Troponin I was measured as marker of cardiac cellular damage.
Results
Peak levels of troponin I release were observed at 4 hours after cardiopulmonary bypass and were not affected by 1 cycle of sevoflurane administration (controls: 14 ± 3 ng/mL vs sevoflurane-I group, 14 ± 3 ng/mL). Two periods of sevoflurane preconditioning significantly reduced cellular damage compared with controls (peak troponin I level sevoflurane-II group, 7 ± 2 ng/mL).
Conclusion
These data show that sevoflurane-induced preconditioning is reproducible in patients having coronary artery bypass but depends on the preconditioning protocol used.
Abbreviations and Acronyms: APC, anesthetic-induced pharmacologic preconditioning of the heart, BNP, brain natriuretic peptide, CABG, coronary artery bypass graft, CI, cardiac index, CK, creatine kinase, CPB, cardiopulmonary bypass, CVP, central venous pressure, dP/dtmax, maximum rate of LV pressure increase, EuroSCORE, European System for Cardiac Operative Risk Evaluation, ICU, intensive care unit, IPC, ischemic preconditioning, LV, left ventricular, MAC, minimum alveolar concentration, MAP, mean arterial pressure, PKC, protein kinase C, TnI, troponin I
CTSNet classification: 1, 25, 30, 31
To access this article, please choose from the options below
Part of the work has been presented at the ASA meeting 2005, Atlanta, and at the ASA annual meeting 2004, Las Vegas.
Support was provided from Deutsche Forschungsgemeinschaft (Bonn, Germany, grant No. SCHL 448/5-1), Siemens Medical Solutions Diagnostics (Fernwald, Germany), Abbott GmbH (Wiesbaden, Germany), and institutional resources.
PII: S0022-5223(08)01740-6
doi:10.1016/j.jtcvs.2008.04.034
© 2009 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Volume 137, Issue 6 , Pages 1436-1442.e2, June 2009
